Aspire-Lakewood Holdings, Inc. (ASBP) vs CASI Pharmaceuticals Inc. (CASIF)
- Aspire-Lakewood Holdings, Inc. ASBP 8.78 +1.62%
- CASI Pharmaceuticals Inc. CASIF 0.10 0.00%
Aspire-Lakewood Holdings, Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. Aspire-Lakewood Holdings, Inc. and CASI Pharmaceuticals Inc. are of similar size ($12.4M and $12.1M). CASI Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire-Lakewood Holdings, Inc. trades at 0.2×. CASI Pharmaceuticals Inc. has the higher net margin (−232.0% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, CASI Pharmaceuticals Inc. leads on 10 and Aspire-Lakewood Holdings, Inc. on 4.
Valuation
Profitability
| Metric | ASBP | CASIF | Biotechnology median |
|---|---|---|---|
| Gross margin | (24.97%) | 48.65% | 65.16% |
| Operating margin | (7,491.61%) | (206.87%) | 0.00% |
| Net margin | (11,309.31%) | (232.03%) | 0.00% |
| Free cash flow margin | (7,355.07%) | (340.20%) | 0.00% |
| Return on equity | (1,032.15%) | 0.00% | (56.36%) |
| Return on assets | (152.09%) | 0.00% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack